» Articles » PMID: 25093883

Microfluidic Organs-on-chips

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2014 Aug 6
PMID 25093883
Citations 1138
Authors
Affiliations
Soon will be listed here.
Abstract

An organ-on-a-chip is a microfluidic cell culture device created with microchip manufacturing methods that contains continuously perfused chambers inhabited by living cells arranged to simulate tissue- and organ-level physiology. By recapitulating the multicellular architectures, tissue-tissue interfaces, physicochemical microenvironments and vascular perfusion of the body, these devices produce levels of tissue and organ functionality not possible with conventional 2D or 3D culture systems. They also enable high-resolution, real-time imaging and in vitro analysis of biochemical, genetic and metabolic activities of living cells in a functional tissue and organ context. This technology has great potential to advance the study of tissue development, organ physiology and disease etiology. In the context of drug discovery and development, it should be especially valuable for the study of molecular mechanisms of action, prioritization of lead candidates, toxicity testing and biomarker identification.

Citing Articles

Organ-on-a-Chip Applications in Microfluidic Platforms.

An L, Liu Y, Liu Y Micromachines (Basel). 2025; 16(2).

PMID: 40047688 PMC: 11857120. DOI: 10.3390/mi16020201.


A Versatile and Modular Microfluidic System for Dynamic Cell Culture and Cellular Interactions.

Ramadan Q, Hazaymeh R, Zourob M Micromachines (Basel). 2025; 16(2).

PMID: 40047680 PMC: 11857257. DOI: 10.3390/mi16020237.


Application of microphysiological systems to unravel the mechanisms of schistosomiasis egg extravasation.

Alfred M, Ochola L, Okeyo K, Bae E, Ogongo P, Odongo D Front Cell Infect Microbiol. 2025; 15:1521265.

PMID: 40041145 PMC: 11876127. DOI: 10.3389/fcimb.2025.1521265.


Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics.

Bokhout L, Campeiro J, Dalm S Eur J Nucl Med Mol Imaging. 2025; .

PMID: 40016527 DOI: 10.1007/s00259-025-07123-3.


Microfluidic Flow Promotes a Steatotic Phenotype in Induced Pluripotent Stem Cell-Derived Hepatocytes that is Influenced by Disease State of the Donor.

Minocha E, Jiang L, Gupta A, Green R, Zohar Y, Wertheim J Gastro Hep Adv. 2025; 4(4):100601.

PMID: 39996239 PMC: 11849064. DOI: 10.1016/j.gastha.2024.100601.


References
1.
Choucha Snouber L, Bunescu A, Naudot M, Legallais C, Brochot C, Dumas M . Metabolomics-on-a-chip of hepatotoxicity induced by anticancer drug flutamide and Its active metabolite hydroxyflutamide using HepG2/C3a microfluidic biochips. Toxicol Sci. 2012; 132(1):8-20. DOI: 10.1093/toxsci/kfs230. View

2.
Atac B, Wagner I, Horland R, Lauster R, Marx U, Tonevitsky A . Skin and hair on-a-chip: in vitro skin models versus ex vivo tissue maintenance with dynamic perfusion. Lab Chip. 2013; 13(18):3555-61. DOI: 10.1039/c3lc50227a. View

3.
Wilkening S, Stahl F, Bader A . Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos. 2003; 31(8):1035-42. DOI: 10.1124/dmd.31.8.1035. View

4.
Sung K, Yang N, Pehlke C, Keely P, Eliceiri K, Friedl A . Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integr Biol (Camb). 2010; 3(4):439-50. PMC: 3094750. DOI: 10.1039/c0ib00063a. View

5.
Lee P, Vandenburgh H . Skeletal muscle atrophy in bioengineered skeletal muscle: a new model system. Tissue Eng Part A. 2013; 19(19-20):2147-55. DOI: 10.1089/ten.TEA.2012.0597. View